Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(25.0%)
Phase 4
1(25.0%)
Early Phase 1
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 1(1)
Phase 4(1)
Early Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01153048Phase 1Completed

Trial on an Educative Structured Intervention by Peer Educators to Improve HbA1c of Patients With Type 2 Diabetes in the Sikasso Region in Mali

Role: collaborator

NCT02346487Phase 3Completed

Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)

Role: collaborator

NCT02348177Phase 4Completed

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Role: collaborator

NCT00532181Early Phase 1Unknown

Micro-Health Insurance in Cambodia

Role: collaborator

All 4 trials loaded